JPS57209268A - Medicinal use of 16-methyl-1,11 alpha,16rs- trihydroxyprost-13e-en-9-one - Google Patents

Medicinal use of 16-methyl-1,11 alpha,16rs- trihydroxyprost-13e-en-9-one

Info

Publication number
JPS57209268A
JPS57209268A JP57092266A JP9226682A JPS57209268A JP S57209268 A JPS57209268 A JP S57209268A JP 57092266 A JP57092266 A JP 57092266A JP 9226682 A JP9226682 A JP 9226682A JP S57209268 A JPS57209268 A JP S57209268A
Authority
JP
Japan
Prior art keywords
trihydroxyprost
alpha
methyl
medicinal use
pharmaceutically acceptable
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP57092266A
Other languages
English (en)
Other versions
JPH0251886B2 (ja
Inventor
Aren Shiyuribaa Debitsudo
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Ortho Pharmaceutical Corp
Original Assignee
Ortho Pharmaceutical Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ortho Pharmaceutical Corp filed Critical Ortho Pharmaceutical Corp
Publication of JPS57209268A publication Critical patent/JPS57209268A/ja
Publication of JPH0251886B2 publication Critical patent/JPH0251886B2/ja
Granted legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/12—Ketones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/557—Eicosanoids, e.g. leukotrienes or prostaglandins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D309/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings
    • C07D309/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
    • C07D309/08—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D309/10—Oxygen atoms
    • C07D309/12—Oxygen atoms only hydrogen atoms and one oxygen atom directly attached to ring carbon atoms, e.g. tetrahydropyranyl ethers

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Treatment And Processing Of Natural Fur Or Leather (AREA)
  • Mechanical Coupling Of Light Guides (AREA)
JP57092266A 1981-06-03 1982-06-01 Medicinal use of 16-methyl-1,11 alpha,16rs- trihydroxyprost-13e-en-9-one Granted JPS57209268A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US06/270,165 US4370348A (en) 1981-06-03 1981-06-03 Method of inducing cytoprotection

Publications (2)

Publication Number Publication Date
JPS57209268A true JPS57209268A (en) 1982-12-22
JPH0251886B2 JPH0251886B2 (ja) 1990-11-08

Family

ID=23030178

Family Applications (1)

Application Number Title Priority Date Filing Date
JP57092266A Granted JPS57209268A (en) 1981-06-03 1982-06-01 Medicinal use of 16-methyl-1,11 alpha,16rs- trihydroxyprost-13e-en-9-one

Country Status (15)

Country Link
US (1) US4370348A (ja)
EP (1) EP0066475B1 (ja)
JP (1) JPS57209268A (ja)
KR (1) KR880001028B1 (ja)
AT (1) ATE22531T1 (ja)
AU (1) AU556621B2 (ja)
CA (1) CA1171785A (ja)
DE (1) DE3273533D1 (ja)
GB (1) GB2101483B (ja)
HK (2) HK85186A (ja)
IE (1) IE54276B1 (ja)
MY (1) MY8700124A (ja)
NZ (1) NZ200680A (ja)
PH (1) PH17999A (ja)
SG (1) SG100287G (ja)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4675182A (en) * 1983-02-12 1987-06-23 Bayer Aktiengesellschaft Complexes of prostaglandins
US4470974A (en) * 1983-06-27 1984-09-11 Merck & Co., Inc. Gastric cytoprotection with L-363,586
US4681759A (en) * 1985-05-08 1987-07-21 Ortho Pharmaceutical Corporation Rioprostil-PVP complex
GB8625325D0 (en) * 1986-10-22 1986-11-26 Glaxo Group Ltd Chemical compounds
US6060233A (en) * 1996-06-14 2000-05-09 Biostore New Zealand, Ltd Methods for the lyophilization of platelets, platelet membranes or erythrocytes
US6040132A (en) * 1996-06-14 2000-03-21 Biostore New Zealand, Ltd. Methods for the lyophilization of living biological materials

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4132738A (en) * 1978-02-23 1979-01-02 Miles Laboratories, Inc. Preparation of 15-deoxy-16-hydroxyprostaglandins

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4132783A (en) * 1976-12-02 1979-01-02 The Dow Chemical Company (Substituted pyridyl)phenoxy phosphorus compounds and their use as insecticides

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4132738A (en) * 1978-02-23 1979-01-02 Miles Laboratories, Inc. Preparation of 15-deoxy-16-hydroxyprostaglandins

Also Published As

Publication number Publication date
IE821328L (en) 1982-12-03
SG100287G (en) 1988-09-30
KR880001028B1 (ko) 1988-06-15
GB2101483A (en) 1983-01-19
CA1171785A (en) 1984-07-31
EP0066475A2 (en) 1982-12-08
EP0066475A3 (en) 1983-01-19
HK85186A (en) 1986-11-21
IE54276B1 (en) 1989-08-16
AU556621B2 (en) 1986-11-13
ATE22531T1 (de) 1986-10-15
NZ200680A (en) 1984-11-09
HK22088A (en) 1988-03-31
US4370348A (en) 1983-01-25
PH17999A (en) 1985-02-28
EP0066475B1 (en) 1986-10-01
MY8700124A (en) 1987-12-31
GB2101483B (en) 1986-03-12
AU8442682A (en) 1982-12-09
DE3273533D1 (en) 1986-11-06
KR830009776A (ko) 1983-12-23
JPH0251886B2 (ja) 1990-11-08

Similar Documents

Publication Publication Date Title
ES8701496A1 (es) Procedimiento para preparar una sal de 9-(1, 3-dihidroxi-2-propoximetil)-guanina farmaceuticamente aceptable
HK3888A (en) Novel bandage for administering beneficial drug
JPS5519276A (en) Administering tool for pheromone administration
JPS5579321A (en) Medical composition for local administration
AU557980B2 (en) Perfluorohydrocarbons as vehicles for drugs
GR82030B (ja)
JPS57209268A (en) Medicinal use of 16-methyl-1,11 alpha,16rs- trihydroxyprost-13e-en-9-one
DE3766885D1 (en) Chlorpheniramine therapie.
SE8204871L (sv) Farmaceutiska preparat, innefattande humant proinsulin
DE3273979D1 (en) 9,10-substituted 2-mesitylimino-3-alkyl-3,4,6,7-tetrahydro-2h-pyrimido(6,1-a)isoquinolin-4-ones, process for their preparation and their use as medicaments
IT1161210B (it) Metodo per modulare la risposta immunitaria con dibenzocicloeptenilideni
EP0322352A3 (en) Use of anti-progestins for preparation of medicaments
DE3161204D1 (en) 2-alkyl-5-hydroxy-1,4-naphthoquinones, process for their manufacture and pharmaceutical preparations containing these compounds
NL7901103A (nl) 1,1-digesubstitueerde octahydroindool 2,3-a chinoli- zinen, farmaceutisch aanvaardbare zouten daarvan; werk- wijze voor de bereiding van deze verbindingen, farmaceutische preparaten waarin zich deze verbindingen bevinden, met vaatverwijdende eigenschappen.
ES555201A0 (es) Procedimiento para la preparacion de un derivado del azol
IT1137246B (it) Procedimento per la preparazione di un derivato del 2,4-diossacicloesanone
ES548683A0 (es) Procedimiento de preparacion de un derivado del 2,3-dihidro-2-oxoindol
IT1153996B (it) Procedimento per la preparazione del 3', 5, 7-triidrossi-4'-metossifal-vone
JPS57123119A (en) Medicinal composition for self immunological disease treatment